Krystal Biotech, Inc.
Krystal Biotech, Inc. (KRYS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KRYS · as of Jun 8, 2026
Key Statistics
Explore Krystal Biotech, Inc. Data
krys stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 17 · Buy rate: 100.0%
The KRYS analyst consensus is Buy, based on ratings from 17 Wall Street analysts over the past 3 months. The average 12-month price target is $326.20, representing +7.65% upside from the current price of $303.01.
Competitors & Peers
krys competitorsKRYS
ACLX
ALKS
ARWR
CRSP
MTSRStock Performance
Full HistoryAbout Krystal Biotech, Inc.
Krystal Biotech, Inc. a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremag…
what is krystal biotech, inc. · krys stock overview · krystal biotech, inc. company profile · who is krystal biotech, inc. ceo · krys NASDAQ · krystal biotech, inc. headquarters · krystal biotech, inc. business segments
About Stock Overview & Key Data
Krystal Biotech, Inc. (KRYS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 20, 2017. As of the latest trading session, KRYS stock price is $303.01, with a market capitalization of $8.9B. The stock has returned +121.19% over the past 12 months and +22.09% year-to-date.
According to 17 Wall Street analysts, the consensus rating for Krystal Biotech, Inc. stock is Buy, with an average 12-month price target of $326.20. In fiscal year 2025, Krystal Biotech, Inc. reported revenue of $389.1M and net income of $204.8M. For detailed data — including Krystal Biotech, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Krystal Biotech, Inc. (KRYS) stock price is $303.01. The stock is traded on NASDAQ under the ticker symbol KRYS. The 52-week range is $127.99 – $319.48.